The Journal of Immunology · 2007 · 107 citations · 57 references
Veterinary MedicineImmunologyInfectious DiseasesImmunology Of Infectious DiseasesParasite ImmunologyVaccinologyAdaptive Immune Responses To ParasitesHost-parasite Immune InteractionsImmunoregulation In Parasitic InfectionInnate Immune Responses To ParasitesParasitic Disease PathogenesisT-cell Responses To ParasitesAdaptive Immunity To Protozoan ParasitesCellular Immune Response To ParasitesImmunopathology Of LeishmaniasisInnate Cytokine ResponsesInnate Immune Evasion By ParasitesInnate Immunity PathwaysLeishmania-specific T Cell ResponsesLeishmaniasis Pathogenesis
The ability to manipulate the Leishmania genome to create genetically modified parasites by introducing or eliminating genes is considered a powerful alternative for developing a new generation vaccine against leishmaniasis. Previously, we showed that the deletion of one allele of the Leishmania infantum silent information regulatory 2 (LiSIR2) locus was sufficient to dramatically affect amastigote axenic proliferation. Furthermore, LiSIR2 single knockout (LiSIR2(+/-)) amastigotes were unable to replicate in vitro inside macrophages. Because this L. infantum mutant persisted in BALB/c mice for up to 6 wk but failed to establish an infection, we tested its ability to provide protection toward a virulent L. infantum challenge. Strikingly, vaccination with a single i.p. injection of LiSIR2(+/-) single knockout elicits complete protection. Thus, vaccinated BALB/c mice showed a reversal of T cell anergy with specific anti-Leishmania cytotoxic activity and high levels of NO production. Moreover, vaccinated mice simultaneously generated specific anti-Leishmania IgG Ab subclasses suggestive of both type 1 and type 2 responses. A strong correlation was found between the elimination of the parasites and an increased Leishmania-specific IFN-gamma/IL-10 ratio. Therefore, we propose that the polarization to a high IFN-gamma/low IL-10 ratio after challenge is a clear indicator of vaccine success. Furthermore these mutants, which presented attenuated virulence, represent a good model to understand the correlatives of protection in visceral leishmaniasis.
57
IL-10 acts on the antigen-presenting cell to inhibit cytokine production by Th1 cells
David Fiorentino, Albert Zlotnik, Paulo Vieira et al. · The Journal of Immunology · 1991 · 1.9K citations · Full text
CD4+CD25+ regulatory T cells control Leishmania major persistence and immunity
Yasmine Belkaid, Ciriaco A. Piccirillo, Susana Méndez et al. · Nature · 2002 · 1.7K citations